Therapeutic Effect of Acarbose of Interventive Treatment of Patients with Impaired Glucose Tolerance
Xiao Shao-mei
Abstract
Xiao Shao-mei
Abstract
Objective To investigate the therapeutic efficacy of Acarbose on patients with impaired glucose tolerance. Methods While 120 cases of impaired glucose tolerance were controled diet plus excercise for 1 year, the variations of fasting plasma glucose (FPG),post prandial plasma glucose (2HPG),2 hours after oral glucose tolerance test (OGTT), insulin (PINS) 2 hours after fasting insulin and OGTT, insulin resistance leves in two groups were observed with Acarbose or placebo borandomly and double-blinded. Results There was no significant difference of the sugar tolerance between placebo group and Acarbose group in pretherapy (P0.05). An incidence of diabetes of placebo group was 8.3%; compared to placebo group,the FPG, 2 hPG,FINS and PINS, insulin resistance index were obviously decreased in two groups after treatment of Acarbose ,while with an incidence of diabetes of 5.0%. Conclusion Application of Acarbose in the intervening treatment of IGT subjects can reduce the incidence of diabetes and improve glucose tolerance,while it can degrade insulin resistance.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the therapeutic efficacy of Acarbose on patients with impaired glucose tolerance. Methods While 120 cases of impaired glucose tolerance were controled diet plus excercise for 1 year, the variations of fasting plasma glucose (FPG),post prandial plasma glucose (2HPG),2 hours after oral glucose tolerance test (OGTT), insulin (PINS) 2 hours after fasting insulin and OGTT, insulin resistance leves in two groups were observed with Acarbose or placebo borandomly and double-blinded. Results There was no significant difference of the sugar tolerance between placebo group and Acarbose group in pretherapy (P0.05). An incidence of diabetes of placebo group was 8.3%; compared to placebo group,the FPG, 2 hPG,FINS and PINS, insulin resistance index were obviously decreased in two groups after treatment of Acarbose ,while with an incidence of diabetes of 5.0%. Conclusion Application of Acarbose in the intervening treatment of IGT subjects can reduce the incidence of diabetes and improve glucose tolerance,while it can degrade insulin resistance.
Key concepts: Acarbose, Impaired glucose tolerance, Medicine, Placebo, Internal medicine, Insulin resistance, Diabetes mellitus, Endocrinology